or Try an Advanced Search...

    Treatment Of Cardiovascular Diseases Stocks List

    Symbol Grade Name % Change
    HRTS D Tema Cardiovascular and Metabolic ETF 0.76
    GILD F Gilead Sciences, Inc. 0.30
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Cardiovascular Disease Angina Antibiotics Biopharmaceutical Coronavirus Cystic Fibrosis Cytomegalovirus Retinitis Disease Fungal Infection Fungal Infections Gilead Sciences HIV Hepatotoxins Hypertension Immunodeficiency Infection Inflammation Influenza Investment Management Liver Disease

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cardiovascular Diseases stocks.

    Symbol Grade Name Weight
    IBBQ C Invesco Nasdaq Biotechnology ETF 7.44
    BIS D ProShares UltraShort Nasdaq Biotechnology 7.41
    IBB C iShares Nasdaq Biotechnology Index Fund 7.34
    BBH B Market Vectors Biotech ETF 7.17
    BIB C ProShares Ultra Nasdaq Biotechnology 5.15
    View all Treatment Of Cardiovascular Diseases ETFs...
    Compare ETFs
    Compare BIS to BBH Compare IBB to BIB Compare IBBQ to BIB

        Treatment Of Cardiovascular Diseases Stocks Recent News

        Date Stock Title
        May 31 GILD Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
        May 31 GILD Gilead's Trodelvy falls short in significantly improving overall survival in NSCLC
        May 31 GILD EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024
        May 31 GILD Gilead’s Trodelvy misses goal in bladder cancer study
        May 31 GILD Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
        May 30 GILD Gilead's Trodelvy misses primary endpoint in phase 3 bladder cancer trial
        May 30 GILD Gilead Provides Update on Phase 3 TROPiCS-04 Study
        May 29 GILD Buy Low, Hold Long: 2 Crushed Dividend Stocks To Buy For High Yields And Long-Term Gains
        May 29 GILD Gilead and Cartography enter deal to develop cancer therapies
        May 29 HRTS Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
        May 28 GILD Gilead Sciences: Seriously Undervalued At Peak Pessimism
        May 28 GILD Gilead partnering with Cartography Biosciences to discover cancer therapies
        May 28 GILD Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
        May 28 GILD 2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years
        May 27 GILD Gilead Sciences: Disappointing Fundamentals And Sentiment, But Still Bullish
        May 27 GILD Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows
        May 26 GILD Wall Street Breakfast: The Week Ahead
        May 25 GILD Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Cardiovascular Disease Angina Antibiotics Biopharmaceutical Coronavirus Cystic Fibrosis Cytomegalovirus Retinitis Disease Fungal Infection Fungal Infections Gilead Sciences HIV Hepatotoxins Hypertension Immunodeficiency Infection Inflammation Influenza Investment Management Liver Disease
        Treatment Of Cardiovascular Diseases

        Browse All Tags